ATE294173T1 - 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden - Google Patents

1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden

Info

Publication number
ATE294173T1
ATE294173T1 AT98952391T AT98952391T ATE294173T1 AT E294173 T1 ATE294173 T1 AT E294173T1 AT 98952391 T AT98952391 T AT 98952391T AT 98952391 T AT98952391 T AT 98952391T AT E294173 T1 ATE294173 T1 AT E294173T1
Authority
AT
Austria
Prior art keywords
azanaphthyl
phenylmethyl
dopamine
piperazine
naphthyl
Prior art date
Application number
AT98952391T
Other languages
English (en)
Inventor
William Greenlee
Ashit Ganguly
Jan W F Wasley
Original Assignee
Neurogen Corp
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurogen Corp, Schering Corp filed Critical Neurogen Corp
Application granted granted Critical
Publication of ATE294173T1 publication Critical patent/ATE294173T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT98952391T 1997-10-24 1998-10-21 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden ATE294173T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US95435397A 1997-10-24 1997-10-24
PCT/US1998/022233 WO1999021850A1 (en) 1997-10-24 1998-10-21 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazines being dopamine d4 receptor subtype ligands

Publications (1)

Publication Number Publication Date
ATE294173T1 true ATE294173T1 (de) 2005-05-15

Family

ID=25495312

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98952391T ATE294173T1 (de) 1997-10-24 1998-10-21 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1- phenylmethyl)piperazine als dopamin d4 subtype liganden

Country Status (11)

Country Link
EP (1) EP1025097B1 (de)
CN (1) CN1191248C (de)
AR (1) AR015983A1 (de)
AT (1) ATE294173T1 (de)
AU (1) AU9810498A (de)
CA (1) CA2308057A1 (de)
CO (1) CO4970840A1 (de)
DE (1) DE69829989T2 (de)
ES (1) ES2241172T3 (de)
WO (1) WO1999021850A1 (de)
ZA (1) ZA989720B (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6040448A (en) * 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
WO2000012500A2 (en) * 1998-09-02 2000-03-09 Neurogen Corporation 2-aryl-4-(1-[4-heteroaryl]piperazin-1-yl) methylimidazoles: dopamine d4 receptor subtype ligands
EP1177792A3 (de) 2000-07-27 2002-10-23 Pfizer Products Inc. Dopamin-d4-ligande zur behandlung von gaudi-suchenden krankheiten
PE20060115A1 (es) 2004-07-23 2006-03-23 Basf Ag 2-(piridin-2-il)-pirimidinas como agentes fungicidas
NZ560917A (en) 2005-03-31 2011-01-28 Pfizer Prod Inc Cyclopentapyridine and tetrahydroquinoline derivatives
ES2314940T3 (es) 2005-06-27 2009-03-16 F. Hoffmann-La Roche Ag Guanidinas sustituidas con cloro.
CN103992270B (zh) * 2014-05-13 2016-06-08 泸州医学院 2-氯-5,6,7,8-四氢喹啉的制备方法
MX381417B (es) 2014-08-28 2025-03-12 Asceneuron Sa Inhibidores de glucosidasa.
CN108884077A (zh) 2016-02-25 2018-11-23 阿森纽荣股份公司 糖苷酶抑制剂
JP6971999B2 (ja) 2016-02-25 2021-11-24 エースニューロン・ソシエテ・アノニム ピペラジン誘導体の酸付加塩
US11261183B2 (en) 2016-02-25 2022-03-01 Asceneuron Sa Sulfoximine glycosidase inhibitors
JP2019506430A (ja) 2016-02-25 2019-03-07 エースニューロン・ソシエテ・アノニム グリコシダーゼ阻害剤
AU2017400271B2 (en) 2017-02-24 2020-09-24 Asceneuron S.A. Sulfoximine glycosidase inhibitors
US11458140B2 (en) 2017-08-24 2022-10-04 Asceneuron Sa Annulated glycosidase inhibitors
US11213525B2 (en) 2017-08-24 2022-01-04 Asceneuron Sa Linear glycosidase inhibitors
US12016852B2 (en) 2018-08-22 2024-06-25 Asceneuron Sa Pyrrolidine glycosidase inhibitors
WO2020039029A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Spiro compounds as glycosidase inhibitors
CA3110032A1 (en) 2018-08-22 2020-02-27 Asceneuron S.A. Succinate and fumarate acid addition salts of piperazine derivatives
US11795165B2 (en) 2018-08-22 2023-10-24 Asceneuron Sa Tetrahydro-benzoazepine glycosidase inhibitors
US20220143042A1 (en) 2019-02-22 2022-05-12 Asceneuron Sa Fused glycosidase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3576809A (en) * 1968-05-06 1971-04-27 Miles Lab 2-substituted derivatives of 6-methoxyquinoline
US3629418A (en) * 1969-02-14 1971-12-21 Miles Lab Process for producing an anti-depressant effect with piperazine quinolines
FI193974A7 (de) * 1973-07-13 1975-01-14 Merck & Co Inc
US4091098A (en) * 1977-04-25 1978-05-23 Merck & Co., Inc. 3-(1-PIPERAZINYL)-1,2,4-BENZOTRIAZINES AND N-oxides
DE2811312A1 (de) * 1978-03-16 1979-09-27 Hoechst Ag Neue isochinolinderivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von arzneimitteln
FR2692264B1 (fr) * 1992-06-12 1994-08-05 Adir Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2734819B1 (fr) * 1995-05-31 1997-07-04 Adir Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
KR20000075918A (ko) * 1997-03-04 2000-12-26 해피 페너 ; 해리 에이치. 페너 2세 도파민 수용체 서브타입 특이적 리간드로서의 1-(이소퀴놀린-1-일)-4-(1-페닐메틸)피페라진

Also Published As

Publication number Publication date
AU9810498A (en) 1999-05-17
EP1025097A1 (de) 2000-08-09
AR015983A1 (es) 2001-05-30
CA2308057A1 (en) 1999-05-06
DE69829989D1 (en) 2005-06-02
CN1283195A (zh) 2001-02-07
DE69829989T2 (de) 2006-02-23
ZA989720B (en) 1999-04-26
ES2241172T3 (es) 2005-10-16
EP1025097B1 (de) 2005-04-27
CN1191248C (zh) 2005-03-02
CO4970840A1 (es) 2000-11-07
WO1999021850A1 (en) 1999-05-06

Similar Documents

Publication Publication Date Title
DE69829989D1 (en) 1-(2-naphthyl) und 1-(2-azanaphthyl)-4-(1-phenylmethyl)piperazine als dopamin d4 subtype liganden
ATE318257T1 (de) Trifluoromethylpyrrolcarboxamide und ihre anwendung als fungizide
DE60111540D1 (de) Tetrazolylphenyl-acetamide als glukokinaseaktivatoren
DK1224297T3 (da) Alzheimers sygdom -sekretase, APP-substrater derfor og anvendelser deraf
DE60027433D1 (de) Filtermedien
DK1317451T3 (da) Kemokinreceptorbindende heterocykliske forbindelser
DE60225274D1 (de) Chinolinderivate als liganden für den neuropeptid-y-rezeptor
ID24864A (id) Peranti penyaring
NO20020307D0 (no) N-(indolkarbonyl)piperazinderivater
DE60002249D1 (de) Silikonzusammensetzung und Silikonhaftklebstoff
DE69524925D1 (de) Pyrazinone und ihre Verwendung als Fungizide
DE69907754D1 (de) Filterträger,filterträgeranordnung und system
DE60310552D1 (de) 1-(aminoalkyl)-3-sulfonylindol und -indazol derivative als 5-hydroxytryptamin-6 liganden
ID24663A (id) Turunan-turunan piperazin
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
DE60219422D1 (de) Verbesserte schutzkleidungsgewebe und schutzkleidung
DE60038911D1 (de) 4-Phenylpiperazinyl, -piperidinyl und -tetrahydropyridyl-Derivate als Dopamin D4-Antagonisten
ATE268327T1 (de) Benzazol-verbindungen und ihre verwendung
SE0102384D0 (sv) New compounds
DE50001834D1 (de) Vliesanlage und Betriebsverfahren
DE50009976D1 (de) Kolbenmaschine und Verteilelement
DE50108402D1 (de) N-alkoxyalkyl-substituierte benzimidazole und ihre verwendung als mittel gegen parasitäre protozoen
HUP0001391A3 (en) 1-(isoquinolin-1-yl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
DE60023362D1 (de) Isochinolincarboxamide und ihre Verwendung als anticonvulsiva
IT1320583B1 (it) Ventilatore filtrante.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties